Latest United States Startup Funding Rounds
Startup funding in United States: recent rounds, the companies behind them and their participating investors.
- Rounds
- 2,130 Jan 1 – Oct 9, 2026
- Disclosed funding
- $200B 1764 disclosed amounts
- Median round
- $24M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| E ElucidCompany profile Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk. Clinically validated medical-imaging software that analyzes CT angiography to characterize arterial plaque and help clinicians assess cardiovascular risk. | $55M | Series DSeries C+ | Healthtech | United States | Investors | |
| C CariCompany profile A bank-governed network for moving tokenized commercial-bank deposits in programmable, always-on transactions between participating financial institutions. A bank-governed network for moving tokenized commercial-bank deposits in programmable, always-on transactions between participating financial institutions. | $32.5M | FundingUndisclosed | Fintech | United States | Investors | |
| T TabaPayCompany profile TabaPay provides a unified API for businesses to accept payments and move funds instantly across cards, bank accounts and payment networks. Fintechs, lenders and other platforms use it to collect money and send payouts through the rails their customers can access. TabaPay provides a unified API for businesses to accept payments and move funds instantly across cards, bank accounts and payment networks. Fintechs, lenders and other platforms use it to collect money and send payouts through the rails their customers can access. | $155M | Series B strategic growth financingSeries B | Fintech | United States | Investors | |
| OO Outcomes OneCompany profile Outcomes One connects pharmacies, health plans, and drug manufacturers through clinical-care programs and pharmacy workflow software. Outcomes One connects pharmacies, health plans, and drug manufacturers through clinical-care programs and pharmacy workflow software. | Undisclosed | Growth investmentGrowth | Healthtech | United States | Investors | |
| S SciFinCompany profile SciFin gives enterprise revenue teams a continuously updated view of accounts, deals, forecasts, territories and customer conversations. Its AI companion, Pixie, uses that connected context to answer business questions, identify risks, prepare reports and recommend follow-up actions. SciFin gives enterprise revenue teams a continuously updated view of accounts, deals, forecasts, territories and customer conversations. Its AI companion, Pixie, uses that connected context to answer business questions, identify risks, prepare reports and recommend follow-up actions. | $44M | Seed | AI | United States | Investors | |
| PS Physical Superintelligence (PSI)Company profile Physical Superintelligence develops AI systems that help scientists test physics hypotheses through parallel simulations. Physical Superintelligence develops AI systems that help scientists test physics hypotheses through parallel simulations. | $58M | Seed | AI | United States | Investors | |
| CM Critical Materials GroupCompany profile A U.S. defense manufacturer building modular, automation-ready production systems to expand domestic capacity for military energetics. A U.S. defense manufacturer building modular, automation-ready production systems to expand domestic capacity for military energetics. | $10.3M | Seed | Defense tech | United States | Investors | |
| US Upwind SecurityCompany profile Upwind provides runtime-first cloud security for enterprise security teams. Upwind provides runtime-first cloud security for enterprise security teams. | ~$300M | FundingUndisclosed | Cybersecurity | United States | Investors | |
| D DelfiCompany profile A balance-sheet analytics and decision platform for banks and credit unions, combining risk modeling with financial-product discovery and execution tools. A balance-sheet analytics and decision platform for banks and credit unions, combining risk modeling with financial-product discovery and execution tools. | Undisclosed | Strategic investmentUndisclosed | Fintech | United States | Investors | |
| TC Thyme CareCompany profile Thyme Care combines oncology-trained care teams and technology to support people through cancer treatment while helping health plans and providers improve outcomes and control costs. It monitors patient needs between appointments, coordinates with oncologists and connects members to clinical, practical and social support. Thyme Care combines oncology-trained care teams and technology to support people through cancer treatment while helping health plans and providers improve outcomes and control costs. It monitors patient needs between appointments, coordinates with oncologists and connects members to clinical, practical and social support. | >$125M | Series ESeries C+ | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1Y Combinator (YC)
Nous Research, Santé, Vitalize
125rounds3led - 2Andreessen Horowitz (a16z)
TypeSafe AI, Arena, Vesta
94rounds18led - 3General Catalyst
Minerva Humanoids, Melius
65rounds6led - 4Alumni Ventures
Savvy Wealth, Mona, American Supercritical
55rounds0led - 5Khosla Ventures
Arena, Vinci, Conway Research
54rounds5led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.